{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T17:30:14Z","timestamp":1674927014927},"reference-count":38,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2222\/jsv.57.47","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T05:50:26Z","timestamp":1196142626000},"page":"47-55","source":"Crossref","is-referenced-by-count":3,"title":["Gene therapy using AAV"],"prefix":"10.2222","volume":"57","author":[{"given":"Keiya","family":"OZAWA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"issue":"2","key":"1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","volume":"72","year":"1998","ISSN":"http:\/\/id.crossref.org\/issn\/0022-538X","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2)Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A: Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5: 71-77, 1999.","DOI":"10.1038\/4758"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3)Summerford C, Bartlett JS, Samulski RJ: &alpha;V&beta;<SUB>5<\/SUB> integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5: 78-82, 1999.","DOI":"10.1038\/4768"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.1.609-614.2005"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.15.6884-6893.2001"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00895-06"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00878-06"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8)Pasquale GD, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A, Chiorini JA: Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med 9: 1306-1312, 2003.","DOI":"10.1038\/nm929"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9)Matsushita T, Elliger S, Elliger C, Podsakoff G, Villarreal L, Kurtzman GJ, Iwaki Y, Colosi P: Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther 5: 938-945, 1998.","DOI":"10.1038\/sj.gt.3300680"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10)Urabe M, Xin KQ, Obara Y, Nakakura T, Mizukami H, Kume A, Okuda K, Ozawa K: Removal of empty capsids from type 1 adeno-associated virus vector stocks by anion-exchange chromatography potentiates transgene expression. Mol Ther 13: 823-828, 2006.","DOI":"10.1016\/j.ymthe.2005.11.024"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050083243"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.6.3495-3504.2003"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1038\/ng1179"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1089\/10430349850019364"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15)Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V: Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 2007 (in press).","DOI":"10.1089\/hum.2006.178"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16)Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA: Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5: 56-63, 1999.","DOI":"10.1038\/4743"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17)Riviere C, Danos O, Douar AM: Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther 13: 1300-1308, 2006.","DOI":"10.1038\/sj.gt.3302766"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18)Pruchnic R, Cao B, Peterson ZQ, Xiao X, Li J, Samulski RJ, Epperly M, Huard J: The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. Hum Gene Ther 11: 521-536, 2000.","DOI":"10.1089\/10430340050015716"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19)Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung SH, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, Colosi P, Couto LB, High KA: Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91: 4600-4607, 1998.","DOI":"10.1182\/blood.V91.12.4600.412k22_4600_4607"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20)Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA: Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5: 64-70, 1999.","DOI":"10.1038\/4751"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2000.0219"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.2.791-801.2002"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182412299"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.12.6381-6388.2004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25)Wu Z, Asokan A, Samulski RJ: Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14: 316-327, 2006.","DOI":"10.1016\/j.ymthe.2006.05.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26)Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN, Tuddenham EG, Kemball-Cook G, McIntosh J, Boon-Spijker M, Mertens K, Davidoff AM: Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107: 2653-2661, 2006.","DOI":"10.1182\/blood-2005-10-4035"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1089\/10430340252792486"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28)Wang L, Muramatsu S, Lu Y, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Hanazono Y, Kume A, Urano F, Ichinose H, Nagatsu T, Nakano I, Ozawa K: Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther 9: 381-389, 2002.","DOI":"10.1038\/sj.gt.3301682"},{"key":"29","unstructured":"29)During MJ, Kaplitt MG, Stern MB, Eidelberg D: Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 10: 1589-1591, 2001."},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074549"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1038\/73464"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3296"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33)Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347, 2006.","DOI":"10.1038\/nm1358"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34)Takei Y, Mizukami H, Saga Y, Yoshimura I, Hasumi Y, Takayama T, Kohno T, Matsushita T, Okada T, Kume A, Suzuki M, Ozawa K: Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1\/Flt-1 using adeno-associated virus serotype 1-derived vector. Int J Cancer 120: 278-284, 2007.","DOI":"10.1002\/ijc.22307"},{"key":"35","unstructured":"35)Kohno T, Mizukami H, Suzuki M, Saga Y, Takei Y, Shimpo M, Matsushita T, Okada T, Hanazono Y, Kume A, Sato I, Ozawa K: Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res 63: 5091-5094, 2003."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36)Saga Y, Mizukami H, Suzuki M, Urabe M, Kume A, Nakamura T, Sato I, Ozawa K: Expression of HGF\/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival. Gene Ther 8: 1450-1455, 2001.","DOI":"10.1038\/sj.gt.3301553"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.222221899"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.07.025"}],"container-title":["Uirusu"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:40:38Z","timestamp":1621532438000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jsv\/57\/1\/57_1_47\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.57.47","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}